Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Clearside BioMedical, Inc. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 27 | Code: MRS - 18620

Global Markets Directs, Clearside BioMedical, Inc. Product Pipeline Review 2014, provides an overview of the Clearside BioMedical, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Clearside BioMedical, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Clearside BioMedical, Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Clearside BioMedical, Inc.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Clearside BioMedical, Inc.s pipeline products

Reasons to buy

Evaluate Clearside BioMedical, Inc.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Clearside BioMedical, Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Clearside BioMedical, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Clearside BioMedical, Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Clearside BioMedical, Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Clearside BioMedical, Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
Clearside BioMedical, Inc. Snapshot 4
Clearside BioMedical, Inc. Overview 4
Key Information 4
Key Facts 4
Clearside BioMedical, Inc.- Research and Development Overview 5
Key Therapeutic Areas 5
Clearside BioMedical, Inc.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Pipeline Products- Combination Treatment Modalities 9
Clearside BioMedical, Inc.- Pipeline Products Glance 10
Clearside BioMedical, Inc.- Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Clearside BioMedical, Inc.- Early Stage Pipeline Products 11
IND/CTA Filed Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Clearside BioMedical, Inc.- Drug Profiles 13
(triamcinolone acetonide + aflibercept) 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
triamcinolone acetonide 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecules to Inhibit VEGF and PDGF for Wet AMD 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Small Molecules to Inhibit VEGF for Wet AMD 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Clearside BioMedical, Inc.- Pipeline Analysis 20
Clearside BioMedical, Inc.- Pipeline Products by Target 20
Clearside BioMedical, Inc.- Pipeline Products by Route of Administration 21
Clearside BioMedical, Inc.- Pipeline Products by Molecule Type 22
Clearside BioMedical, Inc.- Pipeline Products by Mechanism of Action 23
Clearside BioMedical, Inc.- Recent Pipeline Updates 24
Clearside BioMedical, Inc.- Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25

Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 27
Disclaimer 27

List of Tables

Clearside BioMedical, Inc., Key Information 4
Clearside BioMedical, Inc., Key Facts 4
Clearside BioMedical, Inc.- Pipeline by Indication, 2014 6
Clearside BioMedical, Inc.- Pipeline by Stage of Development, 2014 7
Clearside BioMedical, Inc.- Monotherapy Products in Pipeline, 2014 8
Clearside BioMedical, Inc.- Combination Treatment Modalities in Pipeline, 2014 9
Clearside BioMedical, Inc.- Phase II, 2014 10
Clearside BioMedical, Inc.- IND/CTA Filed, 2014 11
Clearside BioMedical, Inc.- Discovery, 2014 12
Clearside BioMedical, Inc.- Pipeline by Target, 2014 20
Clearside BioMedical, Inc.- Pipeline by Route of Administration, 2014 21
Clearside BioMedical, Inc.- Pipeline by Molecule Type, 2014 22
Clearside BioMedical, Inc.- Pipeline Products by Mechanism of Action, 2014 23
Clearside BioMedical, Inc.- Recent Pipeline Updates, 2014 24
Clearside BioMedical, Inc., Other Locations 25

List of Figures

Clearside BioMedical, Inc. - Pipeline by Top 10 Indication, 2014 6
Clearside BioMedical, Inc. - Pipeline by Stage of Development, 2014 7
Clearside BioMedical, Inc. - Monotherapy Products in Pipeline, 2014 8
Clearside BioMedical, Inc. - Pipeline by Top 10 Target, 2014 20
Clearside BioMedical, Inc. - Pipeline by Top 10 Route of Administration, 2014 21
Clearside BioMedical, Inc. - Pipeline by Top 10 Molecule Type, 2014 22
Clearside BioMedical, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 23

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing